Thomas K. Equels - CEO & President, Director at AIM ImmunoTech Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President, Director
Stock Symbol
AIM on NYSE
All Insider Reports
All Insider Reports

Thomas K. Equels - trading volume in the past year for AIM ImmunoTech Inc.

Holdings reported by Thomas K. Equels for AIM ImmunoTech Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.64M $326K $0.20 Nov 20, 2024 Direct
Options 300K Nov 30, 2023 Direct Common Stock

Transactions reported by Thomas K. Equels for AIM ImmunoTech Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.